Burden of illness in fibromyalgia patients with comorbid depression

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 106-113

  Bateman, Lucinda ^a   Sarzi Puttini, Piercarlo ^b   Burbridge, Claire L ^c   Landen, Jaren W ^d   Masters, Elizabeth T ^d   Brown, Pritha Bhadra ^d   Scavone, Joseph M ^d   Emir, Birol ^d   Vissing, Richard S ^d   Clair, Andrew G ^d   Pauer, Lynne R ^d  

^a Bateman Horne Center of Excellence   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c Clinical Outcomes Solutions Ltd   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

Activity impairment; Antidepressant; Burden; Fibromyalgia; Healthcare resource utilisation; Work productivity

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DYSTHYMIA; FEMALE; FIBROMYALGIA; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; ILLNESS BURDEN; ITALY; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY (TOPIC); PAIN ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SLEEP DISORDER; SPAIN; STRESS; SYMPTOM; UNITED STATES; WORK DISABILITY; WORKING TIME; CLINICAL TRIAL; COST OF ILLNESS; DEPRESSIVE DISORDER; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

ACTIVITIES OF DAILY LIVING; ADULT; ANTIDEPRESSIVE AGENTS; COMORBIDITY; COST OF ILLNESS; DEPRESSIVE DISORDER; DIAGNOSTIC SELF EVALUATION; FEMALE; FIBROMYALGIA; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84977457138     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. WOLFE F, ROSS K, ANDERSON J, RUSSELL IJ, HEBERT L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
2. WHITE KP, SPEECHLEY M, HARTH M, OSTBYE T: The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26: 1570-6.
3. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
4. MEASE PJ, ARNOLD LM, CROFFORD LJ et al.: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 2008; 59: 952-60.
5. ARNOLD LM, HUDSON JI, KECK PE, AUCHENBACH MB, JAVARAS KN, HESS EV: Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006; 67: 1219-25.
6. BENNETT RM, JONES J, TURK DC, RUSSELL IJ, MATALLANA L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007; 8: 27.
7. SCHAEFER C, CHANDRAN A, HUFSTADER M et al.: The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 2011; 9: 71.
8. PERROT S, WINKELMANN A, DUKES E et al.: Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract 2010; 64: 1100-8.
9. PERROT S, SCHAEFER C, KNIGHT T, HUFSTADER M, CHANDRAN AB, ZLATEVA G: Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains. BMC Musculoskelet Disord 2012; 13: 22.
10. KLEINMAN N, HARNETT J, MELKONIAN A, LYNCH W, KAPLAN-MACHLIS B, SILVERMAN SL: Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med 2009; 51: 1384-93.
11. McDONALD M, DIBONAVENTURA MD, ULLMAN S: Musculoskeletal pain in the workforce: the effects of back, arthritis, and fibromyalgia pain on quality of life and work productivity. J Occup Environ Med 2011; 53: 765-70.
12. WHITE LA, BIRNBAUM HG, KALTENBOECK A, TANG J, MALLETT D, ROBINSON RL: Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008; 50: 13-24.
13. CHANDRAN A, SCHAEFER C, RYAN K, BAIK R, MCNETT M, ZLATEVA G: The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm 2012; 18: 415-26.
14. WINKELMANN A, PERROT S, SCHAEFER C et al.: Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy 2011; 9: 125-36.
15. SANCHEZ RJ, URIBE C, LI H et al.: Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin 2011; 27: 663-71.
16. KNIGHT T, SCHAEFER C, CHANDRAN A, ZLATEVA G, WINKELMANN A, PERROT S: Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res 2013; 5:171-80.
17. EPSTEIN SA, KAY G, CLAUW D et al.: Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999; 40: 57-63.
18. WOLFE F, MICHAUD K, LI T, KATZ RS: Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol 2010; 37: 305-15.
19. FULLER-THOMSON E, NIMIGON-YOUNG J, BRENNENSTUHL S: Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey. Rheumatol Int 2012; 32: 853-62.
20. ARNOLD LM, HUDSON JI, HESS EV et al.: Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944-52.
21. BERGER A, DUKES E, MARTIN S, EDELSBERG J, OSTER G: Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007; 61: 1498-508.
22. CHANG MH, HSU JW, HUANG KL et al.: Bidirectional Association Between Depression and Fibromyalgia Syndrome: A Nationwide Longitudinal Study. J Pain 2015; 16: 895-902.
23. ARNOLD LM, SARZI-PUTTINI P, ARSENAULT P et al.: Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, 2-way crossover, double-blind, placebo-controlled study. J Rheumatol 2015; 42: 1237-44.
24. CROFFORD LJ, ROWBOTHAM MC, MEASE PJ et al.: Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-73.
25. MEASE PJ, RUSSELL IJ, ARNOLD LM et al.: A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008; 35: 502-14.
26. ARNOLD LM, RUSSELL IJ, DIRI EW et al.: A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008; 9: 792-805.
27. PAUER L, WINKELMANN A, ARSENAULT P et al.: An international, randomized, doubleblind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol 2011; 38: 2643-52.
28. SERLIN RC, MENDOZA TR, NAKAMURA Y, EDWARDS KR, CLEELAND CS: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61: 277-84.
29. ZELMAN DC, HOFFMAN DL, SEIFELDIN R, DUKES EM: Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain 2003; 106: 35-42.
30. SNAITH RP, ZIGMOND AS: The Hospital Anxiety and Depression Scale manual1994, London: NFER Nelson.
31. HERRMANN C: International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
32. BURCKHARDT CS, CLARK SR, BENNETT RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991; 18: 728-33.
33. BENNETT R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S154-62.
34. RABIN R, DE CHARRO F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-43.
35. REILLY MC, ZBROZEK AS, DUKES EM: The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353-65.
36. BENNETT RM, BUSHMAKIN AG, CAPPELLERI JC, ZLATEVA G, SADOSKY AB: Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 2009; 36: 1304-11.
37. BUREAU OF LABOR STATISTICS: Employment status of the civilian noninstitutional population by age, sex, and race. 2014 [cited February 13]; Available from: http://www.bls.gov/cps/cpsaat03.pdf.
38. MANN R, SCHAEFER C, SADOSKY A et al.: Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord 2013; 51: 564-70.
39. SADOSKY A, SCHAEFER C, MANN R et al.: Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes 2013; 6: 79-92.
40. PARSONS B, SCHAEFER C, MANN R et al.: Economic and humanistic burden of posttrauma and post-surgical neuropathic pain among adults in the United States. J Pain Res 2013; 6: 459-69.
41. SCHAEFER C, MANN R, SADOSKY A et al.: Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional survey. J Med Econ 2014; 17: 394-407.
42. SCHAEFER C, SADOSKY A, MANN R et al.: Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study. Clinicoecon Outcomes Res 2014; 6: 483-96.
43. SCHAEFER C, MANN R, MASTERS ET et al.: The comparative burden of chronic widespread pain and fibromyalgia in the United States. Pain Pract 2015: DOI:10.1111/papr.12302 [Epub ahead of print].